Wall Street Analysts Think Regenxbio (RGNX) Could Surge 234.37%: Read This Before Placing a Bet

Shares of Regenxbio (RGNX) have gained 17.7% over the past four weeks to close the last trading session at $12.51, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$41.83 indicates a potential upside of 234.4%. The average comprises 12 short-term price targets ranging from a low of $28 to a high of$61, with a standard deviation of $9.47. While the lowest estimate indicates an in ...